CMS confirmed that the new HGNS C-codes will be assigned to APC 5465, the same APC as CPT 64582, keeping the hospital facility fee at approximately $31,500 and leaving Inspire Medical’s (INSP) overall reimbursement essentially unchanged, Stifel tells investors in a research note. While this removes downside risk, including the possibility of reverting to Inspire IV, uncertainty remains around the physician fee and the impact of the -52 modifier pending further MAC guidance, the firm says. Stifel has a Buy rating on Inspire Medical shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
- Inspire Medical price target lowered to $85 from $95 at Stifel
- Inspire Medical jumps after KeyBanc says CMS ‘appears ready’ to add C-codes
- Inspire Medical halted again for volatility after jumping 34% to $79.11
- Inspire Medical Systems trading resumes
- Inspire Medical jumps after KeyBanc note on CMS codes
